As HIV researchers around the globe work to advance vaccines against the devastating virus, the NIAID has awarded $17.3 million to the University of…

The worldwide Zika vaccine race has reached a new milestone as Plymouth Meeting, PA’s Inovio Pharmaceuticals says it has received the first approval to begin…

The FDA approved PaxVax’s oral cholera vaccine on Friday, making it the first licensed cholera vaccine in the U.S. and the only single-dose cholera vaccine…

The meningococcal vaccine market is set for a shakeup as GlaxoSmithKline--on the heels of recent acquisitions and a launch--is expected to overtake Sanofi for…

The FDA fast-tracked Novavax's RSV candidate for the protection of older adults.

Big Pharma is approaching the current Zika outbreak cautiously with concerns about the marketability of a Zika vaccine.

Bavarian Nordic announced today positive topline results from a Phase I trial of its RSV candidate and revealed a $100 million contract to supply HHS’ BARDA…

As the quest for a Zika vaccine unfolds, Inovio Pharma continues to lead the pack. The Pennsylvania-based vaccine maker announced on Monday that its candidate…